BioCARTIS
↗Mechelen, Belgium
BioCARTIS Group NV is a commercial-stage molecular diagnostics (MDx) company providing innovative next-generation diagnostic solutions for oncology and infectious disease testing. The company specializes in its proprietary Idylla™ Platform, a fully automated sample-to-result, real-time PCR system delivering molecular biomarker results in approximately 3 hours. BioCARTIS offers companion diagnostic tests supporting lung, skin, thyroid, colorectal, endometrial, blood, brain and breast cancer detection, enabling fast treatment selection and treatment progress monitoring. The company operates globally with headquarters in Mechelen, Belgium, serving clinicians, patients, payers, and pharmaceutical partners.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Molecular Diagnostics, Oncology Companion Diagnostics
SIZE & FINANCIALS
Employees:501-1000
Revenue:EUR 60-70M
Founded:2007
Ownership:public
Status:operating
FUNDING
Stage:Public Company
Total Raised:$305M
Investors:Johnson & Johnson Innovation (JJDC), Debiopharm, KBC Private Equity, Aescap
STOCK
Exchange:Euronext Bruxelles
Ticker:BCART
Market Cap:EUR 27.24M
PIPELINE
Stage:Commercial
Lead Drug Stage:Idylla™ Platform - Multiple FDA & IVDR Approved Tests
Modalities:Real-time PCR, Molecular Biomarkers, Companion Diagnostics (CDx)
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Bristol Myers Squibb - Idylla™ CDx MSI Test collaboration, Amgen - Companion diagnostics development, AstraZeneca - Companion diagnostics development, Merck - Patient access to personalized medicine (Middle East/North Africa), Johnson & Johnson - Strategic investor and development partner, Abbott Molecular - Development partnerships
COMPETITION
Position:Niche Player
Competitors:Guardant Health, Natera, Foundation Medicine, Exact Sciences, Myriad Genetics, MDxHealth, Bio-Rad Laboratories, Roche +1 more
LEADERSHIP
Key Executives:
Roger Moody - Chief Executive Officer
Herman Verrelst - Chairman
Anthony Green - Executive Vice President, Corporate and Business Development
Randy Polonsky - Chief Financial Officer
Scientific Founders:Renaud Philippe, Nader Donzel, Rudi Pauwels
Board Members:Herman Verrelst - Chairman
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BioCARTIS and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BioCARTIS. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.